A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer. [electronic resource]
Producer: 19950504Description: 2159-64 p. digitalISSN:- 0008-543X
- Aged
- Aged, 80 and over
- Amino Acid Sequence
- Antineoplastic Agents -- administration & dosage
- Drug Administration Schedule
- Humans
- Insulin-Like Growth Factor I -- analysis
- Insulin-Like Growth Factor II -- analysis
- Male
- Middle Aged
- Molecular Sequence Data
- Neoplasms, Hormone-Dependent -- blood
- Octreotide -- administration & dosage
- Peptides, Cyclic
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Somatostatin -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.